Evidence map›Paper›PMID 32545396›Full record

Trial reportNutrients2020

An Assessment of the Glyconutrient Ambrotose™ on Immunity, Gut Health, and Safety in Men and Women: A Placebo-Controlled, Double-Blind, Randomized Clinical Trial.

Richard J Bloomer, Matthew Butawan, Marie van der Merwe, Faith H Keating

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 2 pooled it
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 syntheses or guidelines pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Richard J BloomerCenter for Nutraceuticals and Dietary Supplement Research, School of Health Studies, 106 Roane Fieldhouse, University of Memphis, Memphis, TN 38152, USA.
Matthew ButawanCenter for Nutraceuticals and Dietary Supplement Research, School of Health Studies, 106 Roane Fieldhouse, University of Memphis, Memphis, TN 38152, USA.
Marie van der MerweCenter for Nutraceuticals and Dietary Supplement Research, School of Health Studies, 106 Roane Fieldhouse, University of Memphis, Memphis, TN 38152, USA.
Faith H KeatingCenter for Nutraceuticals and Dietary Supplement Research, School of Health Studies, 106 Roane Fieldhouse, University of Memphis, Memphis, TN 38152, USA.
University of Memphis · US

Funding

Mannatech private company; no grant number provided
6 · The paper itself

Abstract

backgroundCertain dietary fibers have been reported to improve gut health and cellular immunity. Ambrotose is a glyconutrient supplement that contains mannose-rich polysaccharides (acemannan), reported to improve immune function. A more nutrient-dense version of this dietary supplement has been developed recently, with added aloe leaf gel powder (acemannan). The purpose of this study was to evaluate the impact of the traditional and newly developed Ambrotose products on immunity, gut health, and psychological well-being in healthy men and women.

methodsSeventy-five men and women were randomly assigned in double-blind manner to one of five treatments, as follows: Ambrotose Advanced (AA) at 2 or 4 g daily, Ambrotose LIFE (AL) at 2 or 4 g daily, or placebo. Subjects ingested their assigned treatment daily for eight weeks. Resting heart rate, blood pressure, and measures of psychological well-being were analyzed before and after four and eight weeks of supplementation. Blood samples were collected at the same times and analyzed for zonulin, hematology measures, and cytokines-IL-6, IL-10, IL-1β, and TNF-α (analyzed both with and without stimulation via lipopolysaccharide [LPS]).

resultsAll Ambrotose treatments were well-tolerated. There were no differences among treatments in heart rate or blood pressure across time. Self-reported well-being scores were generally higher for the Ambrotose treatments but there were no changes of statistical significance across time (

Indexed as

Dietary SupplementsGastrointestinal MicrobiomeAdultAgedBlood PressureDietary FiberDouble-Blind MethodFemaleHealthy VolunteersHeart RateHumansImmune SystemLeukocyte CountMaleMannansMiddle AgedacemannanDietary FiberMannansdietary supplementsglyconutritiongut healthimmune functionquality of life

Identifiers

PMID32545396
PMCPMC7353283
OpenAlexW3034255495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.